Sign in
TC

TEXAS CAPITAL BANCSHARES INC/TX (TCBI)·Q4 2024 Earnings Summary

Executive Summary

  • Solid Q4 rebound: GAAP diluted EPS was $1.43 vs. $(1.41) in Q3 and $0.33 in Q4’23 as fee revenue and expense actions, plus the absence of Q3’s AFS loss, drove results; net interest margin (NIM) compressed 23 bps sequentially to 2.93% on lower rates but is expected to expand above 3% in Q1’25 .
  • Balance sheet quality and capital remain strengths: CET1 rose to 11.4%; TCE/TA reached 10.0% (record), supporting a new $200M share repurchase authorization through Jan 31, 2026 .
  • Fee engine scaling: Full-year adjusted fee revenue hit a record; management raised 2025 noninterest revenue target to $270M and expects total revenue growth of high-single to low double-digits, albeit with higher expense to support frontline growth; provision outlook trimmed to 30–35 bps of avg LHI ex-MF for 2025, targeting 1.1% ROAA in 2H25 .
  • Deposits: Reported down $627M q/q on predictable mortgage tax escrow seasonality; excluding that, deposits grew nearly $1B as core relationship momentum persists; noninterest-bearing deposits ex-MF stable at ~14% of total .

What Went Well and What Went Wrong

  • What Went Well

    • Fee momentum and diversification: Management highlighted record, broad-based fee growth across investment banking, treasury and wealth; full-year adjusted fee revenue rose ~30% to $211M; 2025 fee target raised to $270M .
    • Cost discipline: Q4 noninterest expense fell 12% q/q, driven by lower salaries/benefits post Q3 restructuring and adjusted comp accruals; the GAAP efficiency ratio improved to 60.7% in Q4 from 155.8% in Q3 (adjusted 62.3% in Q3) .
    • Capital and liquidity: CET1 11.4% and TCE/TA 10.0%—top-tier cushions—enable continued client-facing posture and buyback authorization; CEO: “the firm has proven that it is poised to deliver in 2025” .
  • What Went Wrong

    • Margin pressure into Q4: NIM declined 23 bps q/q to 2.93% on lower asset yields and mix; net interest income fell $10.5M q/q; management expects NIM >3% in Q1 as deposit repricing catches up .
    • Higher provision/NCOs: Provision rose to $18.0M (from $10.0M), with net charge-offs of $12.1M (22 bps of avg LHI), driven by resolution of previously identified credits .
    • Nonaccrual uptick: Nonaccrual LHI increased to $111.2M (0.50% of LHI) vs. $89.0M (0.40%) in Q3 and $81.4M (0.40%) in Q4’23, though criticized loans fell sharply to $714.0M from $897.7M in Q3 .

Financial Results

P&L and Margins (GAAP)

MetricQ4 2023Q3 2024Q4 2024
Net Interest Income ($MM)$214.7 $240.1 $229.6
Non-Interest Income ($MM)$31.1 $(114.8) $54.1
Provision for Credit Losses ($MM)$19.0 $10.0 $18.0
Net Income to Common ($MM)$15.8 $(65.6) $66.7
Diluted EPS ($)$0.33 $(1.41) $1.43
Net Interest Margin (%)2.93% 3.16% 2.93%
Efficiency Ratio (GAAP) (%)81.9% 155.8% 60.7%
Efficiency Ratio (Adj.) (%)73.8% 62.3% 60.7%
ROAA (%)0.27% (0.78)% 0.88%

Notes: Q3 included a $179.6M AFS securities loss and restructuring costs; Q4 had no comparable charges (non-GAAP reconciliation shows no Q4 adjustments) .

Non-Interest Income Components ($MM)

ComponentQ4 2023Q3 2024Q4 2024
Service Charges on Deposits$5.40 $6.31 $6.99
Wealth Mgmt & Trust Fees$3.30 $4.04 $4.01
Brokered Loan Fees$2.08 $2.40 $2.52
Investment Banking & Advisory$6.91 $34.75 $26.74
Trading Income$3.82 $5.79 $5.49
AFS Debt Sec. Gains/(Losses)$0.00 $(179.58) $0.00
Other$9.63 $11.52 $8.33
Total Non-Interest Income$31.13 $(114.77) $54.07

Balance Sheet and Credit KPIs

KPIQ4 2023Q3 2024Q4 2024
Total Deposits (end) ($MM)$22,371.8 $25,865.3 $25,238.6
Noninterest-Bearing Deposits ($MM)$7,328.3 $9,070.8 $7,485.4
Total Loans HFI ($MM)$20,340.6 $22,294.2 $22,450.1
Nonaccrual LHI ($MM)$81.4 $89.0 $111.2
Net Charge-offs ($MM)$13.8 $6.1 $12.1
ACL/Total Loans HFI (%)1.46% 1.43% 1.45%
Criticized Loans ($MM)$738.2 $897.7 $714.0
CET1 Ratio (%)12.6% 11.2% 11.4%
TCE/TA (%)10.2% 9.7% 10.0%
BVPS ($)$61.37 $66.09 $66.36
TBVPS ($)$61.34 $66.06 $66.32
Total Assets ($MM)$28,356.3 $31,629.3 $30,731.9

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Total Revenue GrowthFY2025High single digit (lower end) High single to low double digit Raised upper end
Noninterest RevenueFY2025$240M target $270M target Raised
Noninterest ExpenseFY2025~$765–$770M High single-digit growth; midpoint ≈$800M (implied) Raised
Provision (as % of avg LHI ex-MF)FY202530–35 bps 30–35 bps Maintained
ROAA Target2H 2025~1.1% ~1.1% Maintained
Deposit Beta (interest-bearing)Mid-2025~60% by midyear New
NIM Outlook1Q 2025>3% expected New
Mortgage Finance Avg. LoansFY2025~4.5–5.0B contemplated earlier ~$5B baseline within revenue path Clarified
Share Repurchase AuthorizationThrough 1/31/26Prior program activeNew $200M authorization; prior authorization terminated New
Preferred DividendMar 17, 2025$0.359375 per TCBIO depositary share declared Announced

Earnings Call Themes & Trends

TopicQ2 2024 (Prev-2)Q3 2024 (Prev-1)Q4 2024 (Current)Trend
Fee income growthRecord IB/trading; fees +22% q/q; IB $37M; treasury fees +14% y/y; 5th straight >3x industry payments growth Record fee quarter; $64.8M; guided Q4 IB pullback to $20–$25M as pipelines rebuild Full-year adjusted fee +30% to $211M; 2025 noninterest revenue target $270M Accelerating, structurally diversifying
Treasury/NIB depositsNIB ex-MF ~14% of total; treasury adoption strong NIB ex-MF +4% y/y; deposit growth strong NIB ex-MF stable ~14% of deposits; second straight quarter of growth Stable to improving
Capital & buybacksCET1 11.62%; $50M buybacks; TCE/TA ~9.6% CET1 11.19%; securities repositioning; capital deployment ongoing CET1 11.38%/11.4%; TCE/TA 10%; new $200M buyback authorization Robust capital; added flexibility
NIM/NIINIM 3.01% (−2 bps); modest NII increase NIM 3.16% (+15 bps) NIM 2.93% (−23 bps); expect >3% in Q1 Near-term dip; expected rebound
Credit qualityACL ex-MF 1.84%; criticized stable; NCOs 0.23% Criticized $897.7M; NCOs $6.1M Criticized fell to $714.0M; NCOs $12.1M; ACL/loans 1.45% Improving criticized; normalized NCOs
Mortgage financeAvg MF loans +24% q/q to $4.4B Avg MF $5.2B; MF deposits/loans ~110% Avg MF +5%; MF deposits/loans ~107% Modest rebound; seasonal patterns
Technology/opsINITIO onboarding; wealth platform overhaul; efficiency focus Tech stack/new workflow efficiencies outlined Structural efficiencies underpin PPNR; continued investments Continuous improvement

Management Commentary

  • Strategic positioning: “Our firm materially progressed its transformation in 2024… full-year adjusted… fee income of $211 million and EPS of $4.43, all reached record levels since the beginning of the transformation.” — Rob Holmes, CEO .
  • Fee engine durability: “We believe the proven success of these still maturing offerings continues to warrant additional investment in products, services and talent.” — CEO on investment banking/treasury/wealth scaling .
  • Capital resilience: “Year-end tangible common equity to tangible assets of 10%, ranking first amongst the largest banks in the country… allow for consistent and proactive market-facing posture.” — CEO .
  • 2025 framework: “Total revenue growth of high single to low double-digit percent… full-year targeted 2025 total noninterest revenue reaching $270 million… noninterest expense growth of high single digits… provision outlook of 30 to 35 bps.” — CFO .
  • Near-term NIM: “Q1 should support actual expansion of margin… north of 3%.” — CFO .

Q&A Highlights

  • Expense path vs. fee growth: 2025 noninterest expense implied around ~$800M, “almost entirely driven by additional frontline talent” in IB and treasury; seasonal Q1 comp adds $15–$17M .
  • Deposit beta/cost trajectory: Management targets ~60% interest-bearing deposit beta by mid-2025; repricing actions already lowered December deposit costs vs. September; rollovers in Q1 support further declines even without Fed cuts .
  • NIM trajectory: Despite seasonal Q1 mortgage warehouse dynamics, NIM expected to exceed 3% in Q1 and be “sustainably above 3%” in 2025 under revenue outlook .
  • Buybacks and capital deployment: Buyback authorization renewed; capital remains a competitive advantage; potential reduced risk-weighting for a subset of mortgage warehouse facilities could create excess regulatory capital .
  • Fee guidance sensitivity: $270M noninterest revenue target viewed achievable “regardless of the rate outlook,” given client onboarding momentum and treasury adoption .

Estimates Context

  • Wall Street consensus (S&P Global) for Q4’24 EPS and revenue was not retrievable due to data access limitations at time of analysis; therefore, we cannot quantify an EPS or revenue beat/miss versus consensus at this time. Values would be retrieved from S&P Global.*

Key Takeaways for Investors

  • Core earnings power improving: Q4 EPS recovery, expense discipline, and fee scaling offset NIM headwinds from lower rates; management guides to >3% NIM in Q1 and 1.1% ROAA in 2H25, supporting upward estimate revisions on margins and returns .
  • Structural fee growth is a differentiator: Investment banking, treasury and wealth are increasingly material, with 2025 noninterest revenue target raised to $270M; expect sustained multiple support if execution persists .
  • Capital optionality enhanced: CET1 11.4%, TCE/TA 10.0% and a new $200M buyback authorization provide levers for capital returns and growth; watch for potential RWA benefits in warehouse risk-weighting .
  • Deposit cost relief underway: Repricing progress and targeted ~60% IB beta by mid-2025 should aid NIM, even absent Fed cuts; additional CD maturities in Q1 are a near-term NII lever .
  • Credit normalization manageable: Criticized loans declined materially q/q; ACL coverage steady; some NCO volatility likely as legacy credits resolve, but portfolio metrics remain conservative .
  • Seasonal noise in mortgage finance: Expect typical Q1 seasonal dynamics but improving trends as the year progresses; MF deposit/loan self-funding remains around ~110% .
  • Governance/talent continuity: CEO Rob Holmes to assume Chairman role post-2025 annual meeting, reinforcing continuity of transformation execution .

Appendix: Additional Items

  • Preferred dividend: Declared $0.359375 per TCBIO depositary share (Series B), payable March 17, 2025 .

All citations:

  • Q4’24 press release and financial tables
  • Q4’24 earnings call transcript (prepared remarks and Q&A)
  • Q3’24 press release and tables
  • Q3’24 and Q2’24 call transcripts (trend context)
  • Leadership press release (Chairman transition)
  • Preferred dividend press release

Footnote: *S&P Global consensus estimates were unavailable at the time of analysis due to data access limits. Values would be retrieved from S&P Global.